Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extrapulmonary Neuroendocrine Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05420636
What this trial is testing

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Who this might be right for
Small-cell Lung CancerNeuroendocrine Carcinoma
Fox Chase Cancer Center 20
Early research (Phase 1)Looking for participantsNCT07509034
What this trial is testing

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Who this might be right for
Extensive-Stage Small Cell Lung CancerExtrapulmonary Neuroendocrine CarcinomaRecurrent or Refractory+1 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07720193
What this trial is testing

A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC

Who this might be right for
Advanced Extrapulmonary Neuroendocrine Carcinoma
Nanjing Leads Biolabs Co.,Ltd 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06951243
What this trial is testing

A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

Who this might be right for
Advanced Extrapulmonary Neuroendocrine Cancer
Beijing GoBroad Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT04042714
What this trial is testing

TAS-102 in Extrapulmonary Neuroendocrine Carcinoma

Who this might be right for
High-grade Extra Pulmonary Neuroendocrine Cancer
Baylor Research Institute 14
Testing effectiveness (Phase 2)Looking for participantsNCT06893783
What this trial is testing

Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients

Who this might be right for
Neuroendocrine Carcinomas (NEC)Neuroendocrine Carcinoma of PancreasNeuroendocrine Carcinoma of Prostate
Inkeun Park 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738159
What this trial is testing

Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma

Who this might be right for
Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)QL1706Lenvatinib+1 more
West China Hospital 92
Early research (Phase 1)Looking for participantsNCT07080242
What this trial is testing

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Who this might be right for
Small Cell Lung Cancer Metastatic or Locally AdvancedNeuroendocrine CancerMetastatic Neuroendocrine Prostate Cancer+8 more
SystImmune Inc. 120
Testing effectiveness (Phase 2)UnknownNCT02695459
What this trial is testing

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Who this might be right for
Neuroendocrine Carcinomas
The Netherlands Cancer Institute 39
Testing effectiveness (Phase 2)Looking for participantsNCT07518602
What this trial is testing

Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma

Who this might be right for
Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
Sun Yat-sen University 34